Skip to content

Relating to the cost of prescription drugs.

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

OR HB 3093 · House Bill · 2019 Regular Session

Stage
Session ended
Started in
House
Sponsors
39
Latest action
Jul 1, 2019

What it does

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of patient assistance programs and information on financial assistance provided to pharmacies, government agencies and advocacy organizations. Excludes proprietary information from disclosure on department's website. \tRequires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. \tRequires insurers to post specified information regarding formulary, tiers and costs to insurer's website. Requires 60-day advance notice to enrollees adversely affected by change in formulary. \tRequires insurer and allows pharmacy to notify insured that if…

Read the full text

Where it stands

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

  1. Introduced (Done)

  2. Committee (Current step)

    In committee · Jul 1, 2019

  3. Floor (Needs attention)

    The session ended first

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money in Oregon.

Work with this bill

Relating to the cost of prescription drugs. | 52